MedTrace Logo

Seasonal Allergic Rhinitis and Driving Ability

NCT00223587 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2008-04-15

No results posted yet for this study

Summary

On-the-road driving performance of untreated seasonal allergic rhinitis patients during the allergic season (exposed) is compared to driving performance outside the allergic season (in winter, not-exposed).

Conditions

  • Seasonal Allergic Rhinitis

Interventions

OTHER

1 week of treatment discontinuation

1 week of treatment discontinuation during allergic rhinitis season

Sponsors & Collaborators

  • UCB Pharma

    collaborator INDUSTRY

  • Utrecht Institute for Pharmaceutical Sciences

    lead OTHER

Principal Investigators

  • Edmund Volkerts, PhD · Utrecht Institute for Pharmaceutical Sciences

  • Joris Verster, PhD · Utrecht Institute for Pharmaceutical Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2007-12-31
Completion
2008-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00223587 on ClinicalTrials.gov